Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Reed

Showing results (801-810 of 816) with videos related to

Pageof 82
Sort By:
Journal of the American College of Cardiology|December 22, 2018
ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular MedicineSteven R Bailey, Joshua A Beckman, Timothy D Dao, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitorsRyan P Wurz, Liping H Pettus, Claire Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2006
Electrically conductive bacterial nanowires produced by Shewanella oneidensis strain MR-1 and other microorganismsYuri A Gorby, Svetlana Yanina, Jeffrey S McLean, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase InhibitorsVictor J Cee, Frank Chavez, Bradley Herberich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2025
Connecting the dots: approaching a standardized nomenclature for molecular connectivity in positron emission tomographyMurray B Reed, Luca Cocchi, Christin Y Sander, et al.
Journal of Medicinal Chemistry|June 11, 2016
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase InhibitorsLiping H Pettus, Kristin L Andrews, Shon K Booker, et al.
Nature Chemical Biology|August 21, 2019
Mycobacterium tuberculosis releases an antacid that remodels phagosomesJeffrey Buter, Tan-Yun Cheng, Marwan Ghanem, et al.
Journal of Medicinal Chemistry|January 10, 2019
Discovery of ( R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological MalignanciesHui-Ling Wang, Kristin L Andrews, Shon K Booker, et al.
Journal of Medicinal Chemistry|May 3, 2012
Structure-based design of a novel series of potent, selective inhibitors of the class I phosphatidylinositol 3-kinasesAdrian L Smith, Noel D D'Angelo, Yunxin Y Bo, et al.
Journal of Medicinal Chemistry|August 18, 2012
Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511Mark H Norman, Kristin L Andrews, Yunxin Y Bo, et al.
Pageof 82

Showing results (801-810 of 816) with videos related to

Sort By:
Pageof 82
Journal of the American College of Cardiology|December 22, 2018
ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular MedicineSteven R Bailey, Joshua A Beckman, Timothy D Dao, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitorsRyan P Wurz, Liping H Pettus, Claire Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2006
Electrically conductive bacterial nanowires produced by Shewanella oneidensis strain MR-1 and other microorganismsYuri A Gorby, Svetlana Yanina, Jeffrey S McLean, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase InhibitorsVictor J Cee, Frank Chavez, Bradley Herberich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2025
Connecting the dots: approaching a standardized nomenclature for molecular connectivity in positron emission tomographyMurray B Reed, Luca Cocchi, Christin Y Sander, et al.
Journal of Medicinal Chemistry|June 11, 2016
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase InhibitorsLiping H Pettus, Kristin L Andrews, Shon K Booker, et al.
Nature Chemical Biology|August 21, 2019
Mycobacterium tuberculosis releases an antacid that remodels phagosomesJeffrey Buter, Tan-Yun Cheng, Marwan Ghanem, et al.
Journal of Medicinal Chemistry|January 10, 2019
Discovery of ( R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological MalignanciesHui-Ling Wang, Kristin L Andrews, Shon K Booker, et al.
Journal of Medicinal Chemistry|May 3, 2012
Structure-based design of a novel series of potent, selective inhibitors of the class I phosphatidylinositol 3-kinasesAdrian L Smith, Noel D D'Angelo, Yunxin Y Bo, et al.
Journal of Medicinal Chemistry|August 18, 2012
Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511Mark H Norman, Kristin L Andrews, Yunxin Y Bo, et al.
Pageof 82